C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 233/64 (2006.01) A61K 31/00 (2006.01) A61K 31/415 (2006.01) A61K 31/4172 (2006.01) A61P 7/02 (2006.01) C07D 233/54 (2006.01) C07D 401/06 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 417/06 (2006.01)
Patent
CA 2419633
The present invention provides compounds of formula (I). These compounds are a class of TAFIa inhibitors, which may be used in treating or preventing atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases and those conditions which benefit from maintaining or enhancing bradykinin levels in the body.
La présente invention concerne des composés de formule (I), qui sont une classe d'inhibiteurs TAFIa (Activate Thrombin activatable Fibrinolysis Inhibitor) particulièrement utilisés dans le traitement d'états pathologiques tels que l'athérosclérose, les adhérences, la cicatrisation dermique, le cancer, les états fibreux, les maladies fibreuses et tous les états qui peuvent bénéficier du maintien ou de l'augmentation des taux de bradykinine dans le corps.
Allerton Charlotte Moira Norfor
Blagg Julian
Bunnage Mark Edward
Steele John
Pfizer Inc.
Smart & Biggar
LandOfFree
Substituted imidazoles as tafia inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazoles as tafia inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazoles as tafia inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1729531